94%Confidence
0Views
FDASource
2026-03-16Date
Summary
Recall of Vista Tears eye drops expands the sterility issue to a different product line from the same manufacturer, Omni Lens. This suggests widespread quality system failures, increasing risk for all brands distributing products from this facility.
Actionable: Review any product portfolios dependent on manufacturing from Omni Lens Pvt. Ltd.
AI Confidence: 94%
Data Points
firmWizcure Pharmaa Private Limited
classificationClass II
statusOngoing
distributionDistributed Nationwide in the USA
productVista Tears Polyethylene Glycol 400 0.4% w/v, Propylene Glycol 0.3% w/v Eye Drops, Dry Eye Relief, Lubricant Drops, Sterile 10 ml (1/3 fl. oz.), Manuf
Get Signals Instantly
Premium subscribers receive every signal via Telegram the moment it fires — hours before it appears here.
Subscribe Now